Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -5.56x is 69% above its 2-year average of -17.96x, near the high end of its 2-year range (-73.84x–0.12x).
28.94% above its 12-month average of -7.82x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -5.04x.
INTEREST COVERAGE RATIO
-5.56x
INTEREST COVERAGE RATIO AVG TTM
-7.82x
INTEREST COVERAGE RATIO AVG 3Y
-17.96x
INTEREST COVERAGE RATIO AVG 5Y
-17.96x
INTEREST COVERAGE RATIO AVG 10Y
-1655.98x
INTEREST COVERAGE RATIO AVG 15Y
-1168.74x
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+28.94%
CURRENT VS 3Y AVG
+69.04%
CURRENT VS 5Y AVG
+69.04%
CURRENT VS 10Y AVG
+99.66%
CURRENT VS 15Y AVG
+99.52%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.44x
median of 527 covered companies
CURRENT VS SECTOR MEDIAN
+13.66%
vs the sector median at left
Xencor, Inc.
Market Cap
$1.81B
Interest Coverage Ratio
-5.56x
TTM Avg
-7.82x
3Y Avg
-17.96x
5Y Avg
-17.96x
Market Cap
$1.81B
Interest Coverage Ratio
13.10x
TTM Avg
134.00x
3Y Avg
134.00x
5Y Avg
76.60x
Market Cap
$1.81B
Interest Coverage Ratio
N/A
TTM Avg
1.77x
3Y Avg
2.62x
5Y Avg
35.29x
Market Cap
$1.83B
Interest Coverage Ratio
-67.60x
TTM Avg
11.86x
3Y Avg
11.86x
5Y Avg
11.86x
Market Cap
$1.83B
Interest Coverage Ratio
1.57x
TTM Avg
2.14x
3Y Avg
5.67x
5Y Avg
7.21x
Market Cap
$1.84B
Interest Coverage Ratio
-6.63x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.77B
Interest Coverage Ratio
-206.92x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.75B
Interest Coverage Ratio
1.43x
TTM Avg
1.58x
3Y Avg
1.58x
5Y Avg
1.43x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Xencor, Inc. (XNCR) | $1.81B | -5.56x | -7.82x | -17.96x | -17.96x |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.81B | 13.10x | 134.00x | 134.00x | 76.60x |
| Azenta, Inc. (AZTA)vs › | $1.81B | N/A | 1.77x | 2.62x | 35.29x |
| Sarepta Therapeutics, Inc. (SRPT)vs › | $1.83B | -67.60x | 11.86x | 11.86x | 11.86x |
| Astrana Health, Inc. (ASTH)vs › | $1.83B | 1.57x | 2.14x | 5.67x | 7.21x |
| Palvella Therapeutics, Inc. (PVLA)vs › | $1.84B | -6.63x | N/A | N/A | N/A |
| Generate Biomedicines, Inc. (GENB)vs › | $1.77B | -206.92x | N/A | N/A | N/A |
| Immunome, Inc. (IMNM)vs › | $1.85B | N/A | N/A | N/A | N/A |
| Surgery Partners, Inc. (SGRY)vs › | $1.75B | 1.43x | 1.58x | 1.58x | 1.43x |
| Novavax, Inc. (NVAX)vs › | $1.86B | 24.98x | 24.98x | 24.98x | 24.98x |
Interest Coverage
-5.6x
Debt/Equity
0.13
Current Ratio
6.39
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -5.04x |
| 2026-03-31 | -16.57x |
| 2025-12-31 | -7.29x |
| 2025-09-30 | -6.20x |
| 2025-06-30 | -4.02x |
| 2025-03-31 | -4.98x |
| 2024-12-31 | 0.12x |
| 2024-09-30 | -69.43x |
| 2024-06-30 | -73.84x |
| 2024-03-31 | -5.65x |
| 2023-12-31 | -4.65x |
| 2018-12-31 | -1317.69x |
| 2018-06-30 | -9430.00x |
| 2018-03-31 | -7662.25x |
| 2017-12-31 | -2776.40x |
| 2017-09-30 | -5496.67x |
| 2017-06-30 | -2556.67x |
| 2017-03-31 | -5173.00x |
| 2016-09-30 | -4627.50x |
| 2016-06-30 | 4855.60x |
| 2016-03-31 | -249.37x |
| 2015-12-31 | 3719.00x |
| 2015-09-30 | -2578.00x |
| 2015-06-30 | -2246.50x |
| 2015-03-31 | -1619.50x |
| 2014-12-31 | -675.00x |
| 2014-09-30 | -3143.50x |
| 2014-06-30 | -1684.33x |
| 2014-03-31 | -1883.50x |
| 2013-12-31 | -3710.00x |
| 2013-06-30 | -1.82x |
| 2013-03-31 | -5.99x |
| 2012-12-31 | -3.88x |
| 2012-09-30 | -3.19x |
